🟢 Anixa Biosciences is trading 5.47% up today as momentum continues

Anixa Biosciences is trading at $3.28 (+5.47%) in pre-market as it extends recent momentum following a strong session on July 8.

• The move appears to be a continuation of recent gains rather than a reaction to a fresh announcement, as no company-specific catalysts were found overnight.
• Sentiment remains supported by recent positive developments, including a Korean patent for the company's breast cancer vaccine and earlier clinical updates.
• A slightly firmer broader market may be providing a tailwind for speculative biotech names, with the Nasdaq Composite up 0.46% pre-market.